Market Watch Highlights: GeneDx Holdings Corp (WGS) Ends on an Upturn Note at 35.53

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, GeneDx Holdings Corp’s stock clocked out at $35.53, up 2.78% from its previous closing price of $34.57. In other words, the price has increased by $2.78 from its previous closing price. On the day, 0.55 million shares were traded. WGS stock price reached its highest trading level at $35.86 during the session, while it also had its lowest trading level at $33.58.

Ratios:

To gain a deeper understanding of WGS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.58.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on July 10, 2024, initiated with a Buy rating and assigned the stock a target price of $43.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 19 ’24 when OPKO HEALTH, INC. sold 50,000 shares for $34.49 per share. The transaction valued at 1,724,520 led to the insider holds 2,646,972 shares of the business.

OPKO HEALTH, INC. sold 50,000 shares of WGS for $1,714,850 on Aug 16 ’24. The 10% Owner now owns 2,696,972 shares after completing the transaction at $34.30 per share. On Aug 15 ’24, another insider, OPKO HEALTH, INC., who serves as the 10% Owner of the company, sold 39,824 shares for $33.08 each. As a result, the insider received 1,317,505 and left with 2,746,972 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WGS now has a Market Capitalization of 957032512 and an Enterprise Value of 967133440. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.93 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 3.969 whereas that against EBITDA is -14.69.

Stock Price History:

Over the past 52 weeks, WGS has reached a high of $37.45, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 17.54%, while the 200-Day Moving Average is calculated to be 161.51%.

Shares Statistics:

It appears that WGS traded 417.62K shares on average per day over the past three months and 383970 shares per day over the past ten days. A total of 25.98M shares are outstanding, with a floating share count of 18.28M. Insiders hold about 32.21% of the company’s shares, while institutions hold 58.61% stake in the company. Shares short for WGS as of 1722384000 were 1900943 with a Short Ratio of 4.55, compared to 1719532800 on 1224247. Therefore, it implies a Short% of Shares Outstanding of 1900943 and a Short% of Float of 19.2.

Most Popular